{"id":10254,"date":"2026-07-15T11:34:38","date_gmt":"2026-07-15T09:34:38","guid":{"rendered":"https:\/\/cleanpeptides.eu\/mots-c-doseringsguide\/"},"modified":"2026-07-15T11:34:38","modified_gmt":"2026-07-15T09:34:38","slug":"mots-c-doseringsguide","status":"publish","type":"page","link":"https:\/\/cleanpeptides.eu\/da\/mots-c-doseringsguide\/","title":{"rendered":"MOTS-c doseringsguide"},"content":{"rendered":"<p><em>Kun til forskningsform\u00e5l \u2014 ikke beregnet til menneskelig brug. Clean Peptides giver ingen r\u00e5dgivning om dosering eller brug. Denne guide samler produktinformation og uafh\u00e6ngigt undervisningsmateriale som forskningsreference; den udg\u00f8r ikke l\u00e6gelig r\u00e5dgivning.<\/em><\/p>\n<h2>Hvad er MOTS-c?<\/h2>\n<p>MOTS-c er et mitokondrie-afledt peptid (MDP) p\u00e5 16 aminosyrer, opdaget i 2015 (dr. Changhan David Lee, USC). Det er kodet i mitokondriegenomets 12S rRNA-gen og fungerer som et retrograd signalmolekyle: det vandrer til cellekernen under metabolisk stress for at regulere genekspression. Dets prim\u00e6re m\u00e5l er AMPK, kroppens metaboliske energisensor, som ogs\u00e5 aktiveres af motion, kaloriebegr\u00e6nsning og metformin \u2014 deraf betegnelsen \u00abmotions-mimetikum\u00bb.<\/p>\n<h2>N\u00f8gleegenskaber<\/h2>\n<ul>\n<li>Mitokondrie-afledt peptid \u2014 kodet i mitokondrie-DNA (12S rRNA-gen).<\/li>\n<li>Peptid p\u00e5 16 aminosyrer \u2014 sekvens MRWQEMGYIFYPRKLR.<\/li>\n<li>AMPK-aktivator \u2014 samme signalvej som motion og metformin.<\/li>\n<li>Retrograd signalering \u2014 flytter fra cytoplasma til kerne under metabolisk stress.<\/li>\n<li>Motions-mimetiske egenskaber \u2014 bedre glukosemetabolisme, fedtsyreoxidation, insulinf\u00f8lsomhed.<\/li>\n<li>Aldersrelateret fald \u2014 de endogene niveauer falder med alderen, korreleret med metabolisk dysfunktion.<\/li>\n<\/ul>\n<h2>S\u00e5dan fastl\u00e6gges doseringen<\/h2>\n<p>Relativt nyt molekyle (2015): intervallet p\u00e5 5-10 mg dagligt stammer fra ekstrapolering af dyredoser, tidlig human forskning og erfaring fra brugerf\u00e6llesskabet. Skels\u00e6ttende studier (Lee et al., 2015) viste forebyggelse af aldersrelateret insulinresistens og kostinduceret fedme hos mus. Evidensniveau: fremvoksende.<\/p>\n<h2>Standard doseringsintervaller<\/h2>\n<figure class=\"wp-block-table\">\n<table style=\"border-collapse:collapse;width:100%\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Niveau<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Dosis\/injektion<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Hyppighed<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Ugentligt i alt<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Noter<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Begynder<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">3x om ugen<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">15 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Vurder tolerance, billig indgang<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">\u00d8vet<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Dagligt (7x\/uge)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">35 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Mest almindelige dosering i f\u00e6llesskabet<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Avanceret<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">10 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Dagligt eller 5x\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">50\u201370 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">M\u00e5lrettede metaboliske m\u00e5l<\/td>\n<\/tr>\n<\/table>\n<\/figure>\n<h2>AMPK-aktivering og metabolisk signalvej<\/h2>\n<p>MOTS-c aktiverer AMPK (cellens energisensor) og skifter cellerne fra anabol til katabol tilstand. Virkninger: \u00f8get glukoseoptag (GLUT4), bedre insulinf\u00f8lsomhed, fedtsyreoxidation (ACC-h\u00e6mning), mitokondriel biogenese (PGC-1), aktivering af cellens stressrespons og regulering af folatcyklussen. Det supplerer \u2014 men erstatter ikke \u2014 den motionsinducerede AMPK-aktivering.<\/p>\n<h2>Rekonstituering og dosering (med de medf\u00f8lgende 3 mL)<\/h2>\n<p>Hvert Clean Peptides-h\u00e6tteglas leveres med 3 mL bakteriostatisk vand (0,9 % benzylalkohol). Alle tal nedenfor foruds\u00e6tter rekonstituering med de fulde 3 mL. P\u00e5 en standard U-100-insulinspr\u00f8jte er 100 enheder = 1 mL.<\/p>\n<p><strong>Hurtig formel:<\/strong> koncentration = h\u00e6tteglassets styrke \u00f7 3 mL; enheder der skal tr\u00e6kkes = dosis (mg) \u00d7 300 \u00f7 h\u00e6tteglassets styrke (mg).<\/p>\n<figure class=\"wp-block-table\">\n<table style=\"border-collapse:collapse;width:100%\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">H\u00e6tteglas (Clean Peptides)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Koncentration<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">5 mg<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">10 mg<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">10 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">3,33 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">150 u<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">300 u<\/td>\n<\/tr>\n<\/table>\n<\/figure>\n<p>Opbevar det rekonstituerede produkt i k\u00f8leskab (2\u20138 \u00b0C) og brug det inden for 28-30 dage.<\/p>\n<h2>Dosering efter m\u00e5l<\/h2>\n<ul>\n<li><strong>Metabolisk optimering \/ insulinf\u00f8lsomhed:<\/strong> 5 mg SC\/dag, 8 uger on, 4 uger off. F\u00f8lg fasteblodsukker\/-insulin, HbA1c, HOMA-IR.<\/li>\n<li><strong>Fedttab \/ kropssammens\u00e6tning:<\/strong> 5\u201310 mg\/dag eller 5x\/uge, 6\u20138 uger on, 4 uger off. Kombin\u00e9r med motion og kaloriestyring.<\/li>\n<li><strong>Pr\u00e6station \/ udholdenhed:<\/strong> 5 mg\/dag eller p\u00e5 tr\u00e6ningsdage, 30\u201360 min f\u00f8r tr\u00e6ning, 4\u20138 uger.<\/li>\n<li><strong>Levetid \/ anti-aldring:<\/strong> 5 mg 3\u20135x\/uge, 8 uger on, 4 uger off, gentaget.<\/li>\n<\/ul>\n<p>Alle m\u00e5l har gavn af samtidig motion (synergistisk AMPK-aktivering).<\/p>\n<h2>Kurprotokoller<\/h2>\n<p>Cykling er en forholdsregel (ingen dokumenteret desensibilisering): det hj\u00e6lper med vurdering og omkostningsstyring.<\/p>\n<figure class=\"wp-block-table\">\n<table style=\"border-collapse:collapse;width:100%\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Protokol<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">I kur<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Uden for kur<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;background:#f4f4f4;text-align:left\">Bedst til<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Standard<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">4\u20138 uger dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">4 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">De fleste brugere<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Udvidet<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">8\u201312 uger dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">4\u20136 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Maksimal metabolisk tilpasning<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Vedligeholdelse<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Kontinuerligt, 3x\/uge<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Ingen<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Langsigtet levetid<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px\">Tr\u00e6nings-tilpasset<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Kun tr\u00e6ningsdage<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Hviledage<\/td>\n<td style=\"border:1px solid #ddd;padding:8px\">Fokus p\u00e5 tr\u00e6ningspr\u00e6station<\/td>\n<\/tr>\n<\/table>\n<\/figure>\n<h2>Kombinationer (stacking)<\/h2>\n<ul>\n<li>MOTS-c + 5-Amino-1MQ \u2014 metabolisk synergi (AMPK + NNMT-h\u00e6mning).<\/li>\n<li>MOTS-c + GLP-1-agonist (Tirzepatid\/Semaglutid) \u2014 v\u00e6gtstyring.<\/li>\n<li>MOTS-c + AOD-9604 \u2014 fedttab (300 mcg SC\/dag).<\/li>\n<li>MOTS-c + Tesamorelin \u2014 metabolisme og kropssammens\u00e6tning.<\/li>\n<\/ul>\n<h2>Sikkerhed, bivirkninger og kontraindikationer<\/h2>\n<p>Begr\u00e6nsede publicerede humane sikkerhedsdata; gunstig dyreprofil; generelt veltolereret. Milde, selvbegr\u00e6nsende: reaktioner ved injektionsstedet, lejlighedsvis mave-tarm-gener, sj\u00e6lden hovedpine, forbig\u00e5ende tr\u00e6thed. Teoretisk: \u00e6ndringer i blodsukker (overv\u00e5g ved diabetes eller glukoses\u00e6nkende medicin). Ingen virkning p\u00e5 kortisol\/prolaktin\/appetit, ingen v\u00e6skeophobning.<\/p>\n<p><strong>Kontraindikationer:<\/strong> aktiv kr\u00e6ft eller kr\u00e6ft i anamnesen; graviditet\/amning; type 1\/insulinkr\u00e6vende diabetes; samtidig glukoses\u00e6nkende medicin (risiko for hypoglyk\u00e6mi); sv\u00e6r lever-\/nyreinsufficiens.<\/p>\n<p><strong>Monitorering:<\/strong> fasteblodsukker, fasteinsulin, HbA1c, HOMA-IR, lipidprofil, kropssammens\u00e6tning. Ikke FDA-godkendt.<\/p>\n<h2>Almindelige fejl<\/h2>\n<ul>\n<li>At behandle MOTS-c som en direkte fedtforbr\u00e6nder (det optimerer stofskiftet over tid).<\/li>\n<li>At bruge oral indtagelse (nul biotilg\u00e6ngelighed \u2014 skal injiceres SC).<\/li>\n<li>At forvente \u00f8jeblikkelige resultater (typisk 2\u20134 uger).<\/li>\n<li>Ikke at kombinere det med motion og kost.<\/li>\n<li>At opbevare rekonstitueret MOTS-c ved stuetemperatur.<\/li>\n<li>At overskride 10 mg dagligt (ingen proportional gevinst).<\/li>\n<li>At fors\u00f8mme metaboliske blodpr\u00f8ver.<\/li>\n<li>At stakke for mange metaboliske stoffer p\u00e5 \u00e9n gang.<\/li>\n<\/ul>\n<h2>Vigtigste pointer<\/h2>\n<ul>\n<li>Mitokondrie-afledt peptid, der virker via nuklear retrograd signalering.<\/li>\n<li>Standarddosis 5\u201310 mg SC dagligt eller 3\u20135x\/uge (milligram, ikke mikrogram).<\/li>\n<li>Prim\u00e6r mekanisme: AMPK-aktivering (som motion, faste, metformin).<\/li>\n<li>Bedst sammen med motion; bedste stacks: 5-Amino-1MQ, GLP-1-agonister, AOD-9604.<\/li>\n<li>Kur 4\u20138 uger on \/ 4 uger off; milde bivirkninger; ikke FDA-godkendt (fremvoksende evidens).<\/li>\n<\/ul>\n<h2>Download og relaterede ressourcer<\/h2>\n<p><a href=\"https:\/\/cleanpeptides.eu\/wp-content\/uploads\/2026\/07\/10-MOTS-c-Dosage-Guide-Clean-Peptides.pdf\">\ud83d\udcc4 Download den fulde PDF-guide<\/a><\/p>\n<p><a href=\"https:\/\/cleanpeptides.eu\/product\/mots-c-10-mg\/\">MOTS-c 10 mg<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/tesamorelin-dosage-guide\/\">Tesamorelin doseringsguide<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/ipamorelin-dosage-guide\/\">Ipamorelin doseringsguide<\/a><\/p>\n<h2>Referencer<\/h2>\n<ol>\n<li>Lee C, Zeng J, Drew BG, et al. \u00abMOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.\u00bb Cell Metab. 2015;21(3):443-454.<\/li>\n<li>Lee C, Kim KH, Cohen P. \u00abMOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism.\u00bb Free Radic Biol Med. 2016;100:182-187.<\/li>\n<li>Kim KH, et al. \u00abMOTS-c translocates to the nucleus to regulate gene expression under metabolic stress.\u00bb Cell Metab. 2018;28(3):516-524.<\/li>\n<li>Reynolds JC, et al. \u00abMOTS-c is an exercise-induced regulator of age-dependent physical decline.\u00bb Nat Commun. 2021;12(1):470.<\/li>\n<li>Yin X, et al. \u00abMOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes.\u00bb Pharmacol Res. 2022;175:105987.<\/li>\n<\/ol>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"excerpt":{"rendered":"<p>Kun til forskningsform\u00e5l \u2014 ikke beregnet til menneskelig brug. Clean Peptides giver ingen r\u00e5dgivning om dosering eller brug. Denne guide [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-10254","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/comments?post=10254"}],"version-history":[{"count":0,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10254\/revisions"}],"wp:attachment":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/media?parent=10254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}